Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection


Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of six HCC prediction models for UK patients with cirrhosis and a hepatitis C virus (HCV) virological cure.

JHEP Reports